Issue #28

Issue #28

December 01, 2022

December 1, 2022 | Issue #28

Good Evening

. Welcome back to another issue of Spannr. We hope you all enjoyed the break! Now let's get back to it.

In this week's newsletter

:

💊 Trending longevity supplements

🤝 How to get more involved in the longevity startup ecosystem

💰 Funding announcements

📢 Business news + weekend reading material

Longevity Supplements: What they are, Benefits, and More

Ask any expert in the field and they'll tell you that frequent exercise, good sleeping habits, and a healthy diet will go a very long way in your quest to live better longer.It's true!But what if you wanted to do a little extra? ...Or, perhaps, boost your health with dietary supplements that may be more cost-effective than treating a particular age-related disease down the line?Well, if you're in that boat, you're not alone. Longevity supplements are becoming increasingly popular as people look for more ways to improve their health and extend their life.In our latest article, we examine the science and potential benefits underpinning 7 popular longevity supplements.

Introducing The Longevity Biotech Fellowship

If you’re looking for a job/career within longevity, an aspiring entrepreneur looking to connect with those in the field, or an investor looking to go deeper into the longevity startup ecosystem – there’s arguably no better place to start than the Longevity Biotech Fellowship (LBF).The Longevity Biotech Fellowship (LBF) – a non-profit community aiming to bring people together to help progress the field of longevity – is opening its doors to a new cohort of entrepreneurs, students, and investors.The upcoming program that’s set to launch in January 2023 represents LBF’s third cohort since its inception. And better yet, as of last week, applications to join are officially back open.For more details about the program, the perks of joining, and what’s new at LBF in 2023, check out our latest post.LBF’s vision to spur growth, break industry barriers, onboard talented individuals, and legitimize the longevity startup ecosystem all for the sake of expanding healthy human lifespan is something that we can all get behind.

  • Cajal Neuroscience, a biotechnology company integrating human genetics, functional genomics and advanced microscopy to discover novel targets and therapeutics for neurodegeneration, launched with the completion of a $96 million Series A financing led by The Column Group and Lux Capital

  • Exer Labs, a company using phone cameras and AI to track patients’ movements, raises $6.5 million for its Remote Therapeutic Monitoring Platform with participation from Backstage Capital and Life Extension Ventures

  • Sarcura secures €7 million to revolutionize cell therapy manufacturing in an oversubscribed Seed Plus funding round co-led by Lansdowne Investment Company Cyprus and IST Cube

  • CatalYm, a company pioneering the reversal of GDF-15-mediated immunosuppression to induce a potent antitumoral immune reaction in non-responsive tumors, closes a €50 million Series C Financing co-led by Brandon Capital and Jeito Capital

  • Escient Pharmaceuticals, a clinical-stage company advancing novel small molecule therapeutics for the potential treatment of a broad range of neurosensory-inflammatory disorders, announced the closing of a $120 million Series C financing co-led by NEA, Abingworth, and Forge Life Science Partners

  • Introducing Amazon Omics – A Purpose-Built Service to Store, Query, and Analyze Genomic and Biological Data at Scale

  • JFK’s nephew links with Harvard and MIT scientists for longevity skin-care brand Aramore

  • Aviv Clinics Announces New Global Aging Consortium of Internationally Recognized Researchers to Advance Innovations in Healthy Agin

  • Sporting a $3.5M price tag, CSL and uniQure's hemophilia B gene therapy crosses FDA finish line

  • Lineage Cell Announces Launch of Phase 2a Study by Genentech of OpRegen in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

  • Andrew Steele explores Bryan Johnson’s "Blueprint" (Andrew Steele on YouTube)

  • The economy of longevity advisory (Medical Economics)

  • How Darren Aronofsky's oddest sci-fi movie inspired a real quest for longevity (Inverse)

  • 4 Things ‘Limitless’ Gets Right About Longevity (Everyday Health)

  • New Alzheimer’s Drug Shows Positive Results but Side Effects (WSJ)

  • Secrets of ‘SuperAgers’ who possess brains as sharp as people 20 to 30 years younger (CNN)

  • Putin Says Russia Will Use AI To Increase Life Expectancy To 80 Years Old (IBT)

  • Blockchain and Longevity? They’re Talking About It (Everything Zoomer)

  • I found out my biological age—and was annoyed by the result (MIT Technology Review)

  • DIY: FMT for Anti-Aging & Biohacking (Lesswrong)

Performance:*

Latest Price: $125.8314d-Return: 0.64% Market Cap: $10.73b

Big Movers:*

Cognition (CGTX): 94.03%Mesoblast (MESO): 19.48%Recursion (RXRX): -14.84%

*Spannr did not send an email on November 24 due to the holiday, therefore we are reporting 14-day returns.